Venous Stenting Clinical Indications

Primary Indications by Anatomic Location

• The American Heart Association recommends venous stenting for significant systemic venous obstruction located between the clavicles and inguinal ligaments, with the strongest evidence supporting iliac vein stenting for post-thrombotic syndrome and acute deep vein thrombosis management (Class I recommendation) 1
• Iliac vein stenting is indicated for relief of significant systemic venous obstruction inferior to the clavicles and above the inguinal ligaments (Class I Indication) 1, 2
• The American College of Cardiology recommends iliac vein stenting for obstructive lesions after catheter-directed thrombolysis, pharmacomechanical CDT, or surgical venous thrombectomy for acute iliofemoral deep vein thrombosis (Class IIa Indications) 3, 4, 5
• Advanced post-thrombotic syndrome with iliac vein obstruction can be treated with stenting to reduce symptoms and heal venous ulcers (Class IIa Indications) 3, 6, 7
• May-Thurner syndrome (iliac vein compression syndrome) can be treated with stenting during acute IFDVT treatment (Class IIa Indications) 4
• Caudal stent extension into the common femoral vein is reasonable when unavoidable for treating iliac vein lesions that extend distally (Class IIa Indication) 3, 5, 6
• For isolated common femoral vein obstruction, a trial of percutaneous transluminal angioplasty without stenting is recommended first (Class IIa Indication) 3, 5
• Pulmonary vein stenosis can be treated with stenting, achieving a 95% success rate versus 42% for angioplasty alone, with lower restenosis (33% vs 72%) 1, 2
• A final stent diameter of at least 10 mm significantly reduces restenosis risk in pulmonary vein stenosis 1

Clinical Scenarios Requiring Urgent/Emergent Stenting

• The American Heart Association recommends immediate stenting for limb-threatening circulatory compromise (phlegmasia cerulea dolens) with IFDVT (Class I) 4
• Urgent stenting is recommended for rapid thrombus extension despite anticoagulation (Class IIa) 4
• Symptomatic deterioration from IFDVT despite anticoagulation is an indication for urgent stenting (Class IIa) 4

Contraindications and Cautions

• Stenting is contraindicated in peripheral veins subject to bending/flexing (neck, axilla, groin) due to high risk of stent collapse 1, 2
• Femoral vein stenting below the inguinal ligament is not recommended unless absolutely unavoidable due to reduced patency (90% vs 84% for iliac-only) 3, 5, 6
• Very small peripheral veins in small patients should be treated with balloon angioplasty alone 1, 2

Post-Stenting Management

• The American College of Cardiology recommends therapeutic anticoagulation with the same dosing, monitoring, and duration as IFDVT patients without stents (Class IIa) 3, 5, 6, 7
• Target INR 2.0-3.0 if using warfarin, or consider direct oral anticoagulants 10
• Antiplatelet therapy can be added to anticoagulation for patients at high risk of rethrombosis after individualized bleeding risk assessment (Class IIb) 3, 5, 6, 7
• Antiplatelet therapy should be continued for at least 3-6 months post-stenting 9

Key Clinical Pearls

• Venous manometry should be performed to confirm pressure gradient before stenting 8, 9
• Post-stenting manometry should confirm gradient resolution 9
• Stent displacement and embolization are more likely in compliant systemic veins compared to arteries 1, 2
• The healing rate for venous ulcers in advanced post-thrombotic syndrome is 56% with stenting 6, 7
• Headache improvement and papilledema improvement in IIH patients are 78-83% and 87-97%, respectively, with stenting 9